LAS VEGAS, NV--(Marketwired - Jan 27, 2015) - Cell MedX Corp. (
For accurate information regarding the Company, please consult the Company's filings with the United States Securities and Exchange Commission, which may be viewed on the Commission's website at www.sec.gov or on the Company's website at www.cellmedx.com/investors/sec-filings.
About Cell MedX Corp.:
Cell MedX Corp. is an early development stage company focused on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications. Through its wholly owned subsidiary, Avyonce Cosmedics Inc., Cell MedX Corp. is also engaged in the resale and marketing of spa technology and equipment.
On behalf of the Board of Directors of Cell MedX Corp.
Frank McEnulty
Chief Executive Officer and President.
Contact Information:
Cell MedX Corp.
http://www.cellmedx.com
310-230-2300 x-1